Clinical trial I-SPARC
Immune response in patients with cancer undergoing vaccination against SARS-CoV-2 (I-SPARC; IJB-COVID-001)
| Trial status | Trial closed |
|---|---|
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | Bordet |
| EudraCT Identifier | 2021-003710-39 |
| Last update |